CHD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.629000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.975970E-02
Normal-vs-Stage2
3.547200E-01
Normal-vs-Stage3
1.266360E-01
Normal-vs-Stage4
9.133600E-01
Stage1-vs-Stage2
4.560400E-01
Stage1-vs-Stage3
4.947400E-01
Stage1-vs-Stage4
9.943900E-02
Stage2-vs-Stage3
2.014200E-01
Stage2-vs-Stage4
3.486600E-01
Stage3-vs-Stage4
1.591050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.615000E-01
Normal-vs-AfricanAmerican
5.300800E-01
Normal-vs-Asian
1.751570E-01
Caucasian-vs-AfricanAmerican
5.163800E-01
Caucasian-vs-Asian
3.217000E-01
AfricanAmerican-vs-Asian
2.141000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.690000E-01
Normal-vs-Female
2.379000E-01
Male-vs-Female
3.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.929400E-01
Normal-vs-Age(41-60Yrs)
6.001200E-01
Normal-vs-Age(61-80Yrs)
2.749400E-01
Normal-vs-Age(81-100Yrs)
4.349600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.420200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.337200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.608800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.749540E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.667800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.233600E-01
Normal-vs-Daily Drinker
5.450200E-02
Normal-vs-Weekly Drinker
2.509800E-01
Normal-vs-Occasional Drinker
9.645600E-01
Normal-vs-Social Drinker
4.838800E-01
Non Drinker-vs-Daily Drinker
5.820200E-01
Non Drinker-vs-Weekly Drinker
7.362200E-01
Non Drinker-vs-Occasional Drinker
2.211900E-02
Non Drinker-vs-Social Drinker
2.138200E-01
Daily Drinker-vs-Weekly Drinker
3.668400E-01
Daily Drinker-vs-Occasional Drinker
3.261200E-03
Daily Drinker-vs-Social Drinker
5.072400E-02
Weekly Drinker-vs-Occasional Drinker
8.211700E-02
Weekly Drinker-vs-Social Drinker
3.946600E-01
Occasional Drinker-vs-Social Drinker
3.140400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.268200E-01
Normal-vs-Grade 2
3.471800E-02
Normal-vs-Grade 3
1.854220E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.580600E-01
Grade 1-vs-Grade 3
1.556440E-01
Grade 1-vs-Grade 4
1.268200E-01
Grade 2-vs-Grade 3
6.158300E-02
Grade 2-vs-Grade 4
3.471800E-02
Grade 3-vs-Grade 4
1.854220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.764400E-01
Normal-vs-NonDiabetic
3.131400E-01
Diabetic-vs-NonDiabetic
7.485400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.618200E-01
Normal-vs-NoPancreatitis
3.199200E-01
Pancreatitis-vs-NoPancreatitis
9.818800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.061000E-01
Normal-vs-N1
3.550200E-01
N0-vs-N1
7.564600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.244600E-01
Normal-vs-TP53-NonMutant
4.869400E-01
TP53-Mutant-vs-TP53-NonMutant
6.975800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
